Application 020538
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.0375MG/24HR | No | No |
| 002 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.075MG/24HR | No | No |
| 003 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.05MG/24HR | No | No |
| 004 | ESTRADIOL | ESTRADIOL | Film, Extended Release; Transdermal | 0.1MG/24HR | No | No |
| 005 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.0375MG/24HR | Yes | No |
| 006 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.05MG/24HR | Yes | No |
| 007 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.075MG/24HR | Yes | No |
| 008 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.1MG/24HR | Yes | Yes |
| 009 | VIVELLE-DOT | ESTRADIOL | FILM, EXTENDED RELEASE;TRANSDERMAL | 0.025MG/24HR | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020538-005 | VIVELLE-DOT | ESTRADIOL | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-006 | VIVELLE-DOT | ESTRADIOL | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-007 | VIVELLE-DOT | ESTRADIOL | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-008 | VIVELLE-DOT | ESTRADIOL | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 |
| N020538-009 | VIVELLE-DOT | ESTRADIOL | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020538-005 | AB1 |
| N020538-006 | AB1 |
| N020538-007 | AB1 |
| N020538-008 | AB1 |
| N020538-009 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | AB1 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | AB1 | 1 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol | ESTRADIOL | Teva Pharmaceuticals USA, Inc. | c4936878-1643-4e7f-9b0d-e4957935aef2 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| ELESTRIN | ESTRADIOL | Viatris Specialty LLC | eff2dea1-f117-11e3-ac10-0800200c9a66 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL |
| Estradiol | ESTRADIOL | A-S Medication Solutions | 31646359-292c-4bca-88a4-7a89b11c3f44 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
| Estrogen 4X | ESTRADIOL | Nutritional Specialties, Inc. | 772c2a8a-10e2-49af-8db6-4d5ca64b1719 | 2023-07-25 | Warnings | ESTRADIOL |
| estradiol | ESTRADIOL | Zydus Lifesciences Limited | 2f2030c2-f72e-4142-9cff-540bc8fbf8a1 | 2023-04-21 | estradiol ESTRADIOL | |
| estradiol | ESTRADIOL | Zydus Lifesciences Limited | 8b672c79-0896-4d6e-b225-299e89068ad7 | 2023-04-21 | estradiol ESTRADIOL | |
| Estradiol | ESTRADIOL | Zydus Lifesciences Limited | b79fd5ea-962f-491c-b670-40efe42ccf79 | 2022-12-07 | Estradiol ESTRADIOL | |
| ESTRADIOL | ESTRADIOL | Asclemed USA, Inc. | 229b4ec5-d3c8-4406-9fc5-8f633c6447b8 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | ESTRADIOL ESTRADIOL |
| Estradiol | ESTRADIOL | PharmPak, Inc. | 8f8c5a0b-4d7b-a5cb-e053-2995a90a494e | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | Estradiol ESTRADIOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0343 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0344 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0345 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0346 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0365 | Vivelle-Dot | estradiol | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7129 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7138 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7144 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7156 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-7167 | Estradiol | estradiol | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
| 68071-3326 | Estradiol | estradiol | NuCare Pharmaceuticals,Inc. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77569 | SUPPL | 2024-02-20 |
| 77546 | SUPPL | 2024-02-16 |
| 69008 | SUPPL | 2021-10-15 |
| 68886 | SUPPL | 2021-10-05 |
| 68885 | SUPPL | 2021-10-05 |
| 68874 | SUPPL | 2021-10-05 |
| 68873 | SUPPL | 2021-10-05 |
| 68541 | SUPPL | 2021-09-03 |
| 50287 | SUPPL | 2017-11-03 |
| 12696 | SUPPL | 2014-08-01 |
| 2687 | SUPPL | 2014-08-01 |
| 34795 | SUPPL | 2013-05-21 |
| 34794 | SUPPL | 2013-05-21 |
| 25134 | SUPPL | 2013-05-21 |
| 25133 | SUPPL | 2013-05-21 |
| 12695 | SUPPL | 2013-05-21 |
| 2686 | SUPPL | 2013-05-21 |
| 41418 | SUPPL | 2006-05-16 |
| 25132 | SUPPL | 2004-08-10 |
| 12694 | SUPPL | 2004-08-10 |
| 12693 | SUPPL | 2004-02-03 |
| 25131 | SUPPL | 2004-02-02 |
| 34793 | SUPPL | 2002-05-03 |
| 34792 | SUPPL | 2002-05-03 |
| 34791 | SUPPL | 2002-05-03 |
| 2685 | SUPPL | 2002-05-03 |
| 2684 | SUPPL | 2002-05-03 |
| 2683 | SUPPL | 2002-05-03 |
| 20708 | SUPPL | 1999-01-08 |
| 12692 | SUPPL | 1999-01-08 |
| 2682 | SUPPL | 1999-01-08 |